What is Genasys' operating income?

Genasys' total operating income in 2025 was -$16.81 million, based on the following breakdown: Total Gross Profit: $16.96 million Total Operating Expenses: $33.77 million

Genasys (GNSS) Financials

$1.72 +0.03 (+1.78%)

Closing price 04:00 PM Eastern

Extended Trading

$1.72 +0.01 (+0.29%)

As of 04:10 PM Eastern

Compare

Annual Income Statements for Genasys

This table shows Genasys' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	9/30/2015	9/30/2016	9/30/2017	9/30/2018	9/30/2019	9/30/2020	9/30/2021	9/30/2022	9/30/2023	9/30/2024	9/30/2025
Net Income / (Loss) Attributable to Common Shareholders	9.69	-1.28	-0.88	-3.75	2.79	12	0.70	-16	-18	-32	-18
Consolidated Net Income / (Loss)	9.69	-1.28	-0.88	-3.75	2.79	12	0.70	-16	-18	-32	-18
Net Income / (Loss) Continuing Operations	9.69	-1.28	-0.88	-3.75	2.79	12	0.70	-16	-18	-32	-18
Total Pre-Tax Income	1.34	-1.47	-0.68	-1.37	3.36	6.17	1.14	-15	-11	-32	-18
Total Operating Income	1.22	-1.59	-0.81	-1.48	3.14	6.04	1.08	-16	-11	-27	-17
Total Gross Profit	8.53	7.67	10	13	18	23	23	27	22	10	17
Total Revenue	17	16	20	26	37	43	47	54	47	24	41
Operating Revenue	17	16	20	26	37	43	47	54	47	24	41
Total Cost of Revenue	8.26	8.69	10	14	19	20	24	27	25	14	24
Operating Cost of Revenue	8.26	8.69	10	14	19	20	24	27	25	14	24
Total Operating Expenses	7.31	9.26	11	14	15	17	22	43	33	37	34
Selling, General & Admin Expense	5.28	6.88	8.59	11	11	12	17	23	25	27	26
Research & Development Expense	2.03	2.39	2.50	3.52	4.53	4.55	4.92	7.01	8.13	9.64	8.11
Total Other Income / (Expense), net	0.12	0.13	0.13	0.11	0.22	0.13	0.05	0.06	-0.01	-5.42	-1.18
Interest Expense	-	-	-	-	-	-	-	-	0.00	0.60	1.58
Interest & Investment Income	-	-	-	-	-	-	-	-	0.14	0.24	0.29
Other Income / (Expense), net	0.12	0.13	0.13	0.11	0.22	0.13	0.05	0.06	-0.15	-5.05	0.11
Income Tax Expense	-8.35	-0.19	0.20	2.38	0.57	-5.71	0.43	0.74	7.40	-0.41	0.12
Basic Earnings per Share	$0.29	($0.04)	($0.03)	($0.12)	$0.09	$0.36	$0.02	($0.44)	($0.50)	($0.72)	($0.40)
Weighted Average Basic Shares Outstanding	33.17M	31.97M	31.86M	32.49M	32.69M	33.22M	34.41M	36.50M	36.94M	44.32M	45.06M
Diluted Earnings per Share	$0.29	($0.04)	($0.03)	($0.12)	$0.08	$0.35	$0.02	-	($0.50)	($0.72)	($0.40)
Weighted Average Diluted Shares Outstanding	33.57M	31.97M	31.86M	32.49M	33.40M	34.09M	35.59M	36.70M	36.94M	44.32M	45.06M
Weighted Average Basic & Diluted Shares Outstanding	32.14M	31.97M	31.86M	32.49M	33.01M	33.57M	36.48M	36.70M	44.03M	44.93M	45.19M
Cash Dividends to Common per Share	$0.00	$0.03	-	-	-	-	-	-	$0.00	$0.00	$0.00

This table shows Genasys' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	9/30/2023	3/31/2024	6/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	-10	-6.94	-6.68	-4.08	-6.14	-6.49	-1.41	-0.82	0.72
Consolidated Net Income / (Loss)	-10	-6.94	-6.68	-4.08	-6.14	-6.49	-1.41	-0.82	0.72
Net Income / (Loss) Continuing Operations	-10	-6.94	-6.68	-4.08	-6.14	-6.49	-1.41	-0.82	0.72
Total Pre-Tax Income	-2.65	-6.94	-6.72	-4.08	-6.07	-6.48	-1.37	-0.69	0.87
Total Operating Income	-2.64	-6.99	-5.36	-5.94	-6.26	-5.93	1.31	-0.35	1.28
Total Gross Profit	5.31	2.18	3.78	3.18	2.61	2.60	8.57	8.18	9.82
Total Revenue	11	5.74	7.17	6.94	6.93	9.86	17	17	16
Operating Revenue	11	5.74	7.17	6.94	6.93	9.86	17	17	16
Total Cost of Revenue	5.39	3.56	3.38	3.76	4.32	7.26	8.46	8.88	5.69
Operating Cost of Revenue	5.39	3.56	3.38	3.76	4.32	7.26	8.46	8.88	5.69
Total Operating Expenses	7.95	9.17	9.15	9.12	8.87	8.52	7.26	8.54	8.54
Selling, General & Admin Expense	6.18	6.64	6.65	6.83	6.65	6.42	5.76	6.64	6.21
Research & Development Expense	1.77	2.53	2.50	2.29	2.22	2.10	1.50	1.90	2.33
Total Other Income / (Expense), net	-0.01	0.05	-1.36	1.86	0.19	-0.55	-2.68	-0.34	-0.41
Interest Expense	-	-	-	0.37	0.35	-	-	0.44	0.33
Interest & Investment Income	-	-	-	0.06	0.04	-	-	0.01	0.01
Other Income / (Expense), net	-0.14	0.05	-1.36	2.17	0.50	-0.55	-1.39	0.09	-0.10
Income Tax Expense	7.42	-0.01	-0.04	0.00	0.07	0.01	0.04	0.13	0.15
Basic Earnings per Share	($0.27)	($0.16)	($0.15)	($0.09)	($0.14)	($0.14)	($0.03)	($0.02)	$0.02
Weighted Average Basic Shares Outstanding	36.94M	44.25M	44.60M	44.91M	45.00M	45.15M	45.06M	45.20M	45.27M
Diluted Earnings per Share	-	($0.16)	($0.15)	($0.09)	($0.14)	($0.14)	($0.03)	($0.02)	$0.02
Weighted Average Diluted Shares Outstanding	36.94M	44.25M	44.60M	44.91M	45.00M	45.15M	45.06M	45.20M	46.01M
Weighted Average Basic & Diluted Shares Outstanding	44.03M	44.59M	44.60M	44.93M	45.15M	45.15M	45.19M	45.21M	45.54M

This table details how cash moves in and out of Genasys' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	9/30/2015	9/30/2016	9/30/2017	9/30/2018	9/30/2019	9/30/2020	9/30/2021	9/30/2022	9/30/2023	9/30/2024	9/30/2025
Net Change in Cash & Equivalents	-5.58	-4.85	-0.66	-1.00	7.71	4.48	-9.47	-0.87	-4.14	-4.23	3.26
Net Cash From Operating Activities	0.14	-1.15	-0.67	1.25	9.86	6.92	6.15	0.47	-9.59	-19	-8.76
Net Cash From Continuing Operating Activities	0.14	-1.15	-0.67	1.25	9.86	6.92	8.04	0.47	-9.59	-19	-8.76
Net Income / (Loss) Continuing Operations	9.69	-1.28	-0.88	-3.75	2.79	12	0.70	-16	-18	-32	-18
Consolidated Net Income / (Loss)	9.69	-1.28	-0.88	-3.75	2.79	12	0.70	-16	-18	-32	-18
Depreciation Expense	0.24	0.17	0.15	0.48	0.83	0.80	1.60	2.56	2.56	2.93	2.78
Amortization Expense	-	-	-	-	0.00	0.60	0.71	0.77	0.78	0.90	0.73
Non-Cash Adjustments To Reconcile Net Income	0.69	0.81	1.00	0.91	0.93	1.48	1.83	16	2.02	6.42	-4.18
Changes in Operating Assets and Liabilities, net	-10	-0.84	-0.95	3.60	5.32	-7.84	3.20	-2.55	3.44	2.03	10
Net Cash From Investing Activities	-4.65	-1.00	-0.13	-2.79	-0.61	-3.14	-16	-0.09	5.54	-8.67	7.90
Net Cash From Continuing Investing Activities	-4.65	-1.00	-0.13	-2.79	-0.61	-3.14	-16	-0.09	5.54	-8.67	7.90
Purchase of Property, Plant & Equipment	-0.34	-0.16	-0.18	-0.63	-0.34	-0.14	-0.21	-0.38	-0.24	-0.19	-0.26
Acquisitions	-0.01	-0.01	0.00	-2.43	-	0.00	-16	-	0.00	-0.91	0.00
Purchase of Investments	-4.30	-0.83	-2.91	-4.92	-4.50	-8.06	-5.14	-6.83	-3.64	-16	-1.40
Sale and/or Maturity of Investments	-	0.00	2.96	5.19	4.23	5.06	5.65	7.12	9.42	9.40	9.56
Other Investing Activities, net	-	-	-	-	-	-	-	-	0.00	-0.76	0.00
Net Cash From Financing Activities	-1.06	-2.70	0.13	0.60	-1.49	0.68	0.01	-1.06	-0.11	24	4.03
Net Cash From Continuing Financing Activities	-1.06	-2.70	0.13	0.60	-1.49	0.68	0.01	-1.06	-0.11	24	4.03
Issuance of Debt	-	-	0.00	0.06	-	-	-	-	0.00	14	4.00
Issuance of Common Equity	-	-	-	-	-	-	-	-	0.00	10	0.00
Other Financing Activities, net	0.50	0.00	0.13	2.43	0.70	1.09	0.07	0.21	-0.11	-0.27	0.03
Effect of Exchange Rate Changes	-	-	0.00	-0.06	-0.05	0.02	-0.08	-0.19	0.03	-	0.09
Cash Interest Paid	-	-	0.00	0.02	0.00	-	-	-	0.00	0.60	1.58
Cash Income Taxes Paid	-	-	-	-	-	-	-	-	0.00	0.05	0.24

This table details how cash moves in and out of Genasys' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	9/30/2023	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	5.70	5.13	-3.73	3.53	-2.47	-0.55	2.75	2.32	-9.36
Net Cash From Operating Activities	3.23	-7.51	0.56	0.95	-6.32	-5.90	2.51	7.20	-9.31
Net Cash From Continuing Operating Activities	3.23	-7.51	0.57	0.95	-6.32	-5.88	2.49	6.22	-8.34
Net Income / (Loss) Continuing Operations	-10	-6.68	-11	-4.08	-6.14	-6.49	-1.41	-0.82	0.72
Consolidated Net Income / (Loss)	-10	-6.68	-11	-4.08	-6.14	-6.49	-1.41	-0.82	0.72
Depreciation Expense	0.64	0.73	0.74	0.74	0.69	0.69	0.67	0.68	0.69
Amortization Expense	0.20	0.20	0.32	0.23	0.11	0.19	0.20	0.00	0.41
Non-Cash Adjustments To Reconcile Net Income	0.42	0.48	4.10	-1.64	-0.01	-2.38	-0.14	9.20	-5.74
Changes in Operating Assets and Liabilities, net	12	-2.24	6.80	5.71	-0.97	2.11	3.18	-2.84	-4.42
Net Cash From Investing Activities	2.46	-1.04	-4.28	2.63	3.83	1.43	0.01	0.04	-0.04
Net Cash From Continuing Investing Activities	2.46	-1.04	-4.28	2.63	3.83	1.43	0.01	0.04	-0.04
Purchase of Property, Plant & Equipment	-0.01	-0.01	-0.03	-0.07	-0.16	0.01	-0.04	0.00	-0.04
Net Cash From Financing Activities	0.05	14	-0.04	0.00	0.02	4.00	0.01	-4.93	0.01
Net Cash From Continuing Financing Activities	0.05	14	-0.26	0.00	0.02	3.78	0.23	-3.97	-0.96
Other Financing Activities, net	0.05	-	-0.26	0.00	0.02	-0.22	0.23	0.03	-0.96
Other Net Changes in Cash	-	-	-	-	-	-	-	0.01	-0.01
Cash Interest Paid	-	-	-	0.37	-	0.41	0.45	0.44	0.33
Cash Income Taxes Paid	-	-	-	0.01	-	0.02	0.20	0.11	0.15

This table presents Genasys' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	9/30/2015	9/30/2016	9/30/2017	9/30/2018	9/30/2019	9/30/2020	9/30/2021	9/30/2022	9/30/2023	9/30/2024	9/30/2025
Total Assets	40	37	39	42	47	66	90	72	50	54	64
Total Current Assets	27	25	29	28	34	40	35	36	25	26	39
Cash & Equivalents	18	13	13	11	19	23	13	13	8.67	4.95	7.97
Short-Term Investments	1.25	2.94	4.36	3.59	3.70	4.27	5.69	6.40	1.48	7.95	0.07
Accounts Receivable	2.12	3.41	5.68	2.79	3.64	5.44	7.68	6.74	5.95	3.28	7.60
Inventories, net	4.93	4.76	5.26	6.73	5.84	5.95	6.42	6.01	6.50	7.31	8.81
Prepaid Expenses	0.57	0.60	0.98	3.09	1.78	0.86	2.26	3.58	1.85	2.41	8.74
Other Current Assets	-	-	-	-	-	-	-	-	-	0.15	6.12
Plant, Property, & Equipment, net	0.47	0.47	0.51	2.45	2.27	1.93	1.76	1.76	1.55	1.29	1.13
Total Noncurrent Assets	12	11	9.30	12	11	24	53	35	23	27	23
Goodwill	-	-	0.00	2.45	2.31	2.47	24	10	10	13	13
Intangible Assets	0.06	0.06	0.06	1.56	1.18	0.94	13	11	8.43	8.51	6.15
Other Noncurrent Operating Assets	0.58	0.39	0.20	0.58	0.56	5.81	6.34	5.76	4.44	4.42	3.85
Total Liabilities & Shareholders' Equity	40	37	39	42	47	66	90	72	50	54	64
Total Liabilities	1.72	2.24	3.67	8.37	12	17	24	21	16	36	62
Total Current Liabilities	1.57	2.08	3.67	6.58	9.27	10	17	15	11	14	54
Short-Term Debt	-	-	0.00	0.30	0.28	0.30	0.30	-	-	0.00	18
Accounts Payable	0.70	0.57	1.11	3.08	0.86	1.37	2.16	2.33	2.79	4.03	8.18
Accrued Expenses	0.87	1.50	2.56	3.20	8.13	7.88	14	12	7.47	7.42	7.45
Customer Deposits	-	-	-	-	-	-	-	-	-	1.61	20
Other Current Liabilities	-	-	-	-	0.00	0.77	0.90	0.95	1.01	1.02	1.13
Total Noncurrent Liabilities	0.15	0.17	0.00	1.79	2.47	6.71	6.70	6.10	4.83	22	7.27
Noncurrent Deferred Revenue	-	-	-	-	-	-	-	-	0.55	0.37	1.48
Other Noncurrent Operating Liabilities	0.15	0.17	0.00	1.74	2.43	6.69	6.70	6.10	4.28	9.91	5.79
Total Equity & Noncontrolling Interests	38	35	35	33	35	49	66	50	34	18	2.17
Total Preferred & Common Equity	38	35	35	33	35	49	66	50	34	18	2.17
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	38	35	35	33	35	49	66	50	34	18	2.17
Common Stock	88	86	88	90	90	91	107	109	110	126	127
Retained Earnings	-50	-52	-53	-57	-54	-42	-41	-57	-76	-108	-126
Accumulated Other Comprehensive Income / (Loss)	-0.00	-0.00	-0.00	-0.25	-0.46	-0.25	0.00	-0.79	-0.51	-0.34	0.69

This table presents Genasys' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026
Period end date	3/31/2024	6/30/2024	12/31/2024	3/31/2025	6/30/2025	12/31/2025	3/31/2026
Total Assets	51	59	55	50	57	68	62
Total Current Assets	22	32	28	23	32	44	39
Cash & Equivalents	3.54	8.67	8.47	5.67	5.34	10	0.93
Short-Term Investments	3.01	4.05	5.15	1.41	0.12	0.03	0.03
Accounts Receivable	2.82	5.66	3.02	3.62	4.65	8.88	13
Inventories, net	6.56	7.32	7.50	8.68	11	8.57	9.67
Prepaid Expenses	6.32	5.93	3.78	3.95	7.46	9.08	12
Other Current Assets	-	-	-	-	2.85	7.15	3.33
Plant, Property, & Equipment, net	1.48	1.37	1.23	1.28	1.17	1.02	0.95
Total Noncurrent Assets	27	26	25	25	24	23	22
Goodwill	13	13	13	13	13	13	13
Intangible Assets	9.74	9.12	7.89	7.30	6.72	5.57	4.99
Other Noncurrent Operating Assets	4.29	4.06	4.05	4.33	4.12	3.61	3.47
Total Liabilities & Shareholders' Equity	51	59	55	50	57	68	62
Total Liabilities	16	31	41	42	54	66	59
Total Current Liabilities	12	12	21	23	49	60	53
Short-Term Debt	-	-	-	-	17	14	15
Accounts Payable	2.60	3.56	4.50	4.17	7.80	7.46	9.65
Accrued Expenses	8.31	7.68	16	17	23	7.28	8.54
Customer Deposits	-	-	-	-	-	30	19
Other Current Liabilities	1.03	1.03	1.03	1.05	1.08	1.15	1.16
Total Noncurrent Liabilities	4.22	19	20	19	4.84	5.83	5.44
Noncurrent Deferred Revenue	-	-	0.38	0.29	0.29	1.21	1.81
Other Noncurrent Operating Liabilities	4.22	6.97	7.16	5.95	4.55	4.62	3.63
Total Equity & Noncontrolling Interests	35	28	14	8.06	3.16	1.81	3.03
Total Preferred & Common Equity	35	28	14	8.06	3.16	1.81	3.03
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	35	28	14	8.06	3.16	1.81	3.03
Common Stock	125	125	126	127	127	128	128
Retained Earnings	-90	-96	-112	-118	-124	-127	-126
Accumulated Other Comprehensive Income / (Loss)	-0.45	-0.47	-0.54	-0.46	0.68	0.69	0.64

This table displays calculated financial ratios and metrics derived from Genasys' official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	9/30/2015	9/30/2016	9/30/2017	9/30/2018	9/30/2019	9/30/2020	9/30/2021	9/30/2022	9/30/2023	9/30/2024	9/30/2025
DEI Shares Outstanding	33,118,600.00	31,798,853.00	31,925,103.00	32,936,721.00	32,593,869.00	33,490,544.00	36,142,093.00	36,596,005.00	37,181,071.00	-	45,154,504.00
DEI Adjusted Shares Outstanding	33,118,600.00	31,798,853.00	31,925,103.00	32,936,721.00	32,593,869.00	33,490,544.00	36,142,093.00	36,596,005.00	37,181,071.00	-	45,154,504.00
DEI Earnings Per Adjusted Shares Outstanding	0.29	-0.04	-0.03	-0.11	0.09	0.35	0.02	-0.44	-0.49	-	-0.40
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-31.75%	-2.52%	24.16%	29.50%	40.57%	16.31%	9.28%	14.96%	-13.64%	-48.55%	69.76%
EBITDA Growth	-55.55%	-182.31%	59.55%	-68.55%	571.82%	80.94%	-54.54%	-453.20%	35.85%	-258.43%	52.76%
EBIT Growth	-59.89%	-209.44%	53.73%	-101.64%	345.14%	83.74%	-81.55%	-1,459.49%	28.05%	-185.38%	47.42%
NOPAT Growth	166.36%	-112.66%	49.30%	-82.79%	351.73%	347.00%	-94.23%	-1,721.20%	29.26%	-143.18%	37.08%
Net Income Growth	191.18%	-113.23%	31.59%	-327.15%	174.37%	326.36%	-94.07%	-2,402.84%	-13.47%	-72.48%	42.92%
EPS Growth	190.00%	-113.79%	25.00%	-300.00%	166.67%	337.50%	-94.29%	0.00%	0.00%	-44.00%	44.44%
Operating Cash Flow Growth	-98.38%	-946.10%	41.97%	287.74%	687.25%	-29.80%	-11.10%	-92.39%	-2,149.79%	-102.79%	54.96%
Free Cash Flow Firm Growth	-123.05%	-2.54%	-9.77%	34.66%	784.49%	-37.86%	-598.45%	114.92%	-105.49%	-5,434.76%	37.64%
Invested Capital Growth	218.92%	4.22%	8.56%	1.33%	-34.40%	54.24%	154.38%	-32.86%	-24.59%	-28.68%	-25.71%
Revenue Q/Q Growth	-15.04%	3.08%	14.71%	-13.78%	13.68%	16.95%	2.32%	1.87%	-10.26%	0.00%	0.00%
EBITDA Q/Q Growth	-7.65%	-57.71%	65.06%	-129.51%	189.01%	77.86%	-34.48%	-1,074.34%	56.02%	0.00%	0.00%
EBIT Q/Q Growth	-8.47%	-44.76%	58.40%	-152.52%	395.26%	106.51%	-66.91%	-653.21%	47.16%	0.00%	0.00%
NOPAT Q/Q Growth	545.12%	-39.49%	54.04%	5.17%	709.68%	449.83%	-92.88%	-653.57%	47.97%	0.00%	0.00%
Net Income Q/Q Growth	564.01%	-115.65%	43.66%	-229.43%	562.54%	405.67%	-92.50%	-903.84%	16.98%	0.00%	0.00%
EPS Q/Q Growth	625.00%	-116.00%	50.00%	-300.00%	700.00%	483.33%	100.10%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	-92.67%	-221.80%	-94.15%	152.03%	552.18%	-37.97%	-46.62%	117.11%	18.59%	-15.93%	18.23%
Free Cash Flow Firm Q/Q Growth	-306.86%	80.22%	-49.46%	68.95%	1,679.13%	-45.45%	-24.03%	199.69%	96.30%	0.00%	0.00%
Invested Capital Q/Q Growth	122.18%	6.49%	15.12%	-2.61%	-39.05%	59.06%	7.21%	-32.15%	-36.23%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	50.81%	46.89%	50.60%	48.43%	49.91%	52.64%	49.84%	50.48%	46.64%	42.44%	41.60%
EBITDA Margin	9.41%	-7.95%	-2.59%	-3.37%	11.31%	17.59%	7.32%	-22.49%	-16.70%	-116.36%	-32.38%
Operating Margin	7.26%	-9.74%	-3.98%	-5.61%	8.48%	14.05%	2.31%	-28.74%	-23.54%	-111.28%	-41.24%
EBIT Margin	7.99%	-8.97%	-3.34%	-5.21%	9.08%	14.34%	2.42%	-28.63%	-23.86%	-132.33%	-40.98%
Profit (Net Income) Margin	57.72%	-7.83%	-4.32%	-14.24%	7.53%	27.61%	1.50%	-30.00%	-39.42%	-132.16%	-44.44%
Tax Burden Percent	722.35%	87.32%	129.10%	273.47%	82.96%	192.51%	61.86%	104.79%	167.30%	98.74%	100.66%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	98.78%	101.15%	107.72%
Effective Tax Rate	-622.35%	0.00%	0.00%	0.00%	17.04%	-92.51%	38.14%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	87.46%	-7.12%	-3.39%	-5.92%	17.87%	79.33%	2.13%	-28.75%	-28.86%	-95.30%	-82.64%
ROIC Less NNEP Spread (ROIC-NNEP)	83.67%	-6.32%	-1.68%	10.15%	16.95%	78.45%	2.00%	-2.53%	40.39%	119.55%	-227.72%
Return on Net Nonoperating Assets (RNNOA)	-58.39%	3.59%	0.88%	-4.99%	-9.79%	-51.23%	-0.90%	0.88%	-14.83%	-28.22%	-100.96%
Return on Equity (ROE)	29.07%	-3.53%	-2.51%	-10.91%	8.09%	28.10%	1.22%	-27.87%	-43.69%	-123.52%	-183.60%
Cash Return on Invested Capital (CROIC)	-17.06%	-11.25%	-11.60%	-7.23%	59.42%	36.66%	-85.00%	10.57%	-0.82%	-61.82%	-53.14%
Operating Return on Assets (OROA)	3.65%	-3.84%	-1.80%	-3.39%	7.55%	10.89%	1.46%	-19.10%	-18.29%	-61.19%	-28.36%
Return on Assets (ROA)	26.38%	-3.35%	-2.32%	-9.28%	6.26%	20.96%	0.90%	-20.02%	-30.22%	-61.11%	-30.75%
Return on Common Equity (ROCE)	29.07%	-3.53%	-2.51%	-10.91%	8.09%	28.10%	1.22%	-27.87%	-43.69%	-123.52%	-183.60%
Return on Equity Simple (ROE_SIMPLE)	25.53%	-3.71%	-2.49%	-11.18%	7.87%	24.16%	1.07%	-32.17%	-54.41%	-180.66%	0.00%
Net Operating Profit after Tax (NOPAT)	8.81	-1.12	-0.57	-1.03	2.60	12	0.67	-11	-7.69	-19	-12
NOPAT Margin	52.48%	-6.82%	-2.78%	-3.93%	7.04%	27.04%	1.43%	-20.12%	-16.48%	-77.90%	-28.87%
Net Nonoperating Expense Percent (NNEP)	3.78%	-0.81%	-1.71%	-16.07%	0.92%	0.89%	0.13%	-26.23%	-69.25%	-214.85%	145.08%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	-22.74%	-63.24%	-58.32%
Cost of Revenue to Revenue	49.19%	53.11%	49.40%	51.57%	50.09%	47.36%	50.16%	49.52%	53.36%	57.56%	58.40%
SG&A Expenses to Revenue	31.46%	42.03%	42.27%	40.65%	29.18%	28.00%	37.07%	41.89%	52.76%	113.55%	62.96%
R&D to Revenue	12.09%	14.60%	12.31%	13.39%	12.24%	10.59%	10.46%	12.97%	17.42%	40.17%	19.89%
Operating Expenses to Revenue	43.55%	56.63%	54.57%	54.04%	41.43%	38.59%	47.53%	79.22%	70.18%	153.72%	82.85%
Earnings before Interest and Taxes (EBIT)	1.34	-1.47	-0.68	-1.37	3.36	6.17	1.14	-15	-11	-32	-17
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	1.58	-1.30	-0.53	-0.89	4.18	7.57	3.44	-12	-7.79	-28	-13
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.43	1.72	1.93	3.01	3.09	4.19	2.84	2.01	2.21	9.04	51.05
Price to Tangible Book Value (P/TBV)	1.43	1.72	1.94	3.42	3.42	4.50	6.39	3.41	4.95	0.00	0.00
Price to Revenue (P/Rev)	3.24	3.63	3.35	3.83	2.95	4.79	3.98	1.88	1.60	6.61	2.71
Price to Earnings (P/E)	5.61	0.00	0.00	0.00	39.21	17.35	265.93	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	1.60%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	17.82%	0.00%	0.00%	0.00%	2.55%	5.77%	0.38%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	2.07	2.56	2.89	4.83	7.40	9.82	3.68	2.68	2.79	9.64	9.94
Enterprise Value to Revenue (EV/Rev)	1.89	2.50	2.47	3.23	2.31	4.06	3.54	1.51	1.37	6.56	2.96
Enterprise Value to EBITDA (EV/EBITDA)	20.09	0.00	0.00	0.00	20.41	23.08	48.40	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	23.66	0.00	0.00	0.00	25.42	28.31	146.31	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	3.60	0.00	0.00	0.00	32.80	15.01	248.29	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	233.67	0.00	0.00	67.80	8.66	25.24	27.07	173.84	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	9.87	32.49	0.00	20.36	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.01	0.01	0.01	0.00	0.00	0.00	0.68	8.31
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.68	0.00
Financial Leverage	-0.70	-0.57	-0.52	-0.49	-0.58	-0.65	-0.45	-0.35	-0.37	-0.24	0.44
Leverage Ratio	1.10	1.05	1.08	1.18	1.29	1.34	1.36	1.39	1.45	2.02	5.97
Compound Leverage Factor	1.10	1.05	1.08	1.18	1.29	1.34	1.36	1.39	1.43	2.04	6.43
Debt to Total Capital	0.00%	0.00%	0.00%	1.03%	0.88%	0.64%	0.45%	0.00%	0.00%	40.61%	89.26%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.88%	0.78%	0.61%	0.45%	0.00%	0.00%	0.00%	89.26%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.15%	0.09%	0.04%	0.00%	0.00%	0.00%	40.61%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	98.97%	99.12%	99.36%	99.55%	100.00%	100.00%	59.39%	10.74%
Debt to EBITDA	0.00	0.00	0.00	-0.39	0.07	0.04	0.09	0.00	0.00	-0.43	-1.36
Net Debt to EBITDA	0.00	0.00	0.00	17.95	-5.70	-4.14	-6.02	0.00	0.00	0.04	-0.76
Long-Term Debt to EBITDA	0.00	0.00	0.00	-0.06	0.01	0.00	0.00	0.00	0.00	-0.43	0.00
Debt to NOPAT	0.00	0.00	0.00	-0.34	0.12	0.03	0.44	0.00	0.00	-0.64	-1.53
Net Debt to NOPAT	0.00	0.00	0.00	15.39	-9.17	-2.70	-30.88	0.00	0.00	0.07	-0.85
Long-Term Debt to NOPAT	0.00	0.00	0.00	-0.05	0.01	0.00	0.00	0.00	0.00	-0.64	0.00
Altman Z-Score	18.49	15.00	10.45	6.46	5.64	7.87	4.81	2.10	1.19	-1.41	-2.19
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	17.26	12.12	7.91	4.21	3.67	3.89	2.03	2.31	2.24	1.86	0.72
Quick Ratio	13.77	9.54	6.21	2.65	2.82	3.20	1.52	1.68	1.43	1.15	0.29
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-1.72	-1.76	-1.93	-1.26	8.65	5.37	-27	4.00	-0.22	-12	-7.57
Operating Cash Flow to CapEx	39.45%	-707.91%	-365.70%	200.02%	2,873.18%	4,941.43%	2,956.73%	122.83%	-4,013.81%	-10,185.34%	-3,436.08%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-20.12	-4.80
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-32.26	-5.56
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-32.58	-5.73
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.46	0.43	0.54	0.65	0.83	0.76	0.60	0.67	0.77	0.46	0.69
Accounts Receivable Turnover	5.24	5.92	4.47	6.21	11.50	9.47	7.16	7.49	7.35	5.20	7.49
Inventory Turnover	1.87	1.79	2.00	2.26	2.95	3.46	3.81	4.31	3.98	2.00	2.95
Fixed Asset Turnover	40.34	34.62	41.33	17.78	15.68	20.49	25.51	30.77	28.21	16.90	33.74
Accounts Payable Turnover	10.76	13.59	11.90	6.47	9.39	18.27	13.36	11.91	9.73	4.05	3.90
Days Sales Outstanding (DSO)	69.59	61.63	81.67	58.74	31.73	38.55	50.96	48.72	49.65	70.20	48.71
Days Inventory Outstanding (DIO)	195.02	203.51	182.24	161.30	123.84	105.57	95.71	84.73	91.68	182.43	123.59
Days Payable Outstanding (DPO)	33.92	26.85	30.68	56.44	38.85	19.98	27.32	30.65	37.52	90.05	93.66
Cash Conversion Cycle (CCC)	230.69	238.29	233.23	163.61	116.72	124.15	119.35	102.81	103.82	162.58	78.64
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	15	16	17	18	12	18	45	30	23	16	12
Invested Capital Turnover	1.67	1.04	1.22	1.51	2.54	2.93	1.49	1.43	1.75	1.22	2.86
Increase / (Decrease) in Invested Capital	11	0.65	1.37	0.23	-6.05	6.26	27	-15	-7.47	-6.57	-4.20
Enterprise Value (EV)	32	41	50	85	85	175	167	81	64	158	121
Market Capitalization	54	59	68	101	109	206	187	101	75	159	111
Book Value per Share	$1.15	$1.09	$1.10	$1.02	$1.09	$1.47	$1.83	$1.38	$0.91	$0.39	$0.05
Tangible Book Value per Share	$1.14	$1.09	$1.10	$0.90	$0.98	$1.37	$0.81	$0.81	$0.41	($0.10)	($0.39)
Total Capital	38	35	35	34	36	49	66	50	34	30	20
Total Debt	0.00	0.00	0.00	0.35	0.31	0.32	0.30	0.00	0.00	12	18
Total Long-Term Debt	0.00	0.00	0.00	0.05	0.03	0.02	0.00	0.00	0.00	12	0.00
Net Debt	-23	-19	-18	-16	-24	-31	-21	-20	-11	-1.22	9.97
Capital Expenditures (CapEx)	0.34	0.16	0.18	0.63	0.34	0.14	0.21	0.38	0.24	0.19	0.26
Debt-free, Cash-free Net Working Capital (DFCFNWC)	6.03	6.69	8.25	6.33	2.27	2.23	-0.82	0.96	3.05	-0.93	-5.17
Debt-free Net Working Capital (DFNWC)	26	23	25	21	25	30	18	20	14	12	2.87
Net Working Capital (NWC)	26	23	25	21	25	30	18	20	14	12	-15
Net Nonoperating Expense (NNE)	-0.88	0.17	0.31	2.71	-0.18	-0.24	-0.03	5.34	11	13	6.35
Net Nonoperating Obligations (NNO)	-23	-19	-18	-16	-24	-31	-21	-20	-11	-1.22	9.97
Total Depreciation and Amortization (D&A)	0.24	0.17	0.15	0.48	0.83	1.40	2.30	3.32	3.34	3.83	3.51
Debt-free, Cash-free Net Working Capital to Revenue	35.95%	40.90%	40.61%	24.06%	6.13%	5.18%	-1.74%	1.78%	6.53%	-3.87%	-12.68%
Debt-free Net Working Capital to Revenue	152.53%	141.15%	124.90%	81.30%	67.72%	69.97%	38.97%	37.38%	29.89%	50.21%	7.05%
Net Working Capital to Revenue	152.53%	141.15%	124.90%	80.17%	66.97%	69.28%	38.34%	37.38%	29.89%	50.21%	-37.14%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.29	($0.04)	($0.03)	($0.12)	$0.09	$0.36	$0.02	($0.44)	($0.50)	($0.72)	($0.40)
Adjusted Weighted Average Basic Shares Outstanding	33.17M	31.97M	32.37M	33.19M	32.69M	33.22M	34.41M	36.50M	36.94M	44.32M	45.06M
Adjusted Diluted Earnings per Share	$0.29	($0.04)	($0.03)	($0.12)	$0.08	$0.35	$0.02	($0.44)	$0.00	($0.72)	($0.40)
Adjusted Weighted Average Diluted Shares Outstanding	33.57M	31.97M	32.37M	33.19M	33.40M	34.09M	35.59M	36.50M	44.03M	44.32M	45.06M
Adjusted Basic & Diluted Earnings per Share	$0.29	($0.04)	($0.03)	($0.12)	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	32.14M	31.80M	31.86M	32.49M	33.01M	33.57M	36.48M	36.70M	44.03M	44.93M	45.19M
Normalized Net Operating Profit after Tax (NOPAT)	0.85	-1.12	-0.57	-1.03	2.60	4.23	0.67	-1.66	-7.69	-19	-12
Normalized NOPAT Margin	5.09%	-6.82%	-2.78%	-3.93%	7.04%	9.83%	1.43%	-3.07%	-16.48%	-77.90%	-28.87%
Pre Tax Income Margin	7.99%	-8.97%	-3.34%	-5.21%	9.08%	14.34%	2.42%	-28.63%	-23.56%	-133.85%	-44.15%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-52.68	-10.61
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-31.01	-7.47
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-53.00	-10.77
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-31.33	-7.63
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	-74.49%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	16.15%	-210.92%	0.00%	-19.37%	77.95%	3.35%	0.00%	-6.16%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Genasys' official financial filings.

Metric	Q4 2023	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	9/30/2023	3/31/2024	6/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	37,181,071.00	44,027,121.00	44,594,562.00	-	44,932,968.00	45,154,504.00	45,154,504.00	45,193,561.00	45,212,311.00
DEI Adjusted Shares Outstanding	37,181,071.00	44,027,121.00	44,594,562.00	-	44,932,968.00	45,154,504.00	45,154,504.00	45,193,561.00	45,212,311.00
DEI Earnings Per Adjusted Shares Outstanding	-0.27	-0.16	-0.15	-	-0.14	-0.14	-0.03	-0.02	0.02
Growth Metrics	-	-	-	-	-	-	-	-	-
Revenue Growth	-33.28%	-48.82%	-49.75%	0.00%	20.79%	37.53%	0.00%	145.89%	123.67%
EBITDA Growth	83.61%	-170.47%	-833.01%	0.00%	28.71%	3.31%	0.00%	114.88%	146.12%
EBIT Growth	78.13%	-104.51%	-364.04%	0.00%	17.11%	3.64%	0.00%	93.00%	120.52%
NOPAT Growth	79.33%	-105.10%	-269.72%	0.00%	10.57%	-10.52%	0.00%	94.08%	124.39%
Net Income Growth	27.22%	-103.88%	-369.57%	0.00%	11.52%	2.92%	0.00%	79.97%	111.78%
EPS Growth	0.00%	0.00%	0.00%	0.00%	12.50%	6.67%	0.00%	77.78%	114.29%
Operating Cash Flow Growth	210.78%	0.00%	-40.29%	0.00%	0.00%	21.53%	351.26%	660.30%	-47.31%
Free Cash Flow Firm Growth	-5.19%	-111.94%	-39.81%	0.00%	716.67%	83.50%	0.00%	0.00%	-119.69%
Invested Capital Growth	-24.59%	-10.18%	-23.57%	0.00%	-52.11%	-46.62%	0.00%	-55.88%	22.94%
Revenue Q/Q Growth	-24.97%	0.00%	24.88%	0.00%	-0.12%	42.20%	72.75%	0.22%	-9.14%
EBITDA Q/Q Growth	-213.37%	0.00%	16.55%	0.00%	-76.16%	-7.28%	113.98%	-46.62%	446.17%
EBIT Q/Q Growth	-91.93%	0.00%	3.15%	0.00%	-52.57%	-6.77%	98.80%	-238.46%	547.35%
NOPAT Q/Q Growth	-82.00%	0.00%	23.35%	0.00%	-5.29%	5.28%	122.13%	-126.85%	533.38%
Net Income Q/Q Growth	-607.17%	0.00%	3.69%	0.00%	-50.54%	-5.67%	78.30%	41.97%	188.49%
EPS Q/Q Growth	0.00%	0.00%	6.25%	0.00%	-55.56%	0.00%	78.57%	33.33%	200.00%
Operating Cash Flow Q/Q Growth	160.29%	0.00%	0.00%	70.32%	-767.58%	-1,765.54%	142.55%	186.97%	-229.35%
Free Cash Flow Firm Q/Q Growth	-28.21%	0.00%	380.04%	0.00%	0.00%	-16.67%	-100.00%	0.00%	-131.55%
Invested Capital Q/Q Growth	-36.23%	0.00%	-3.08%	0.00%	12.71%	8.04%	-17.18%	-56.25%	214.07%
Profitability Metrics	-	-	-	-	-	-	-	-	-
Gross Margin	49.62%	37.93%	52.80%	45.79%	37.65%	26.35%	50.33%	47.95%	63.33%
EBITDA Margin	-18.19%	-120.98%	-80.84%	-44.90%	-71.41%	-56.83%	4.60%	2.45%	14.72%
Operating Margin	-24.66%	-121.87%	-74.80%	-85.61%	-90.23%	-60.11%	7.70%	-2.06%	8.27%
EBIT Margin	-25.99%	-120.98%	-93.82%	-58.76%	-83.02%	-65.73%	-0.46%	-1.55%	7.62%
Profit (Net Income) Margin	-94.04%	-120.89%	-93.23%	-58.76%	-88.56%	-65.81%	-8.27%	-4.79%	4.66%
Tax Burden Percent	380.45%	99.93%	99.38%	100.00%	101.17%	100.12%	102.92%	118.06%	83.29%
Interest Burden Percent	95.11%	100.00%	100.00%	100.00%	105.44%	100.00%	1,753.85%	262.12%	73.50%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	16.71%
Return on Invested Capital (ROIC)	-30.23%	0.00%	0.00%	0.00%	0.00%	0.00%	18.10%	-8.47%	27.08%
ROIC Less NNEP Spread (ROIC-NNEP)	22.91%	0.00%	0.00%	0.00%	0.00%	0.00%	-5.23%	-69.53%	23.48%
Return on Net Nonoperating Assets (RNNOA)	-8.41%	0.00%	0.00%	0.00%	0.00%	0.00%	-24.06%	-8.40%	40.58%
Return on Equity (ROE)	-38.65%	0.00%	0.00%	0.00%	0.00%	0.00%	-5.96%	-16.87%	67.66%
Cash Return on Invested Capital (CROIC)	-0.82%	0.00%	0.00%	0.00%	0.00%	0.00%	-62.33%	0.00%	0.00%
Operating Return on Assets (OROA)	-19.92%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.32%	-1.29%	8.13%
Return on Assets (ROA)	-72.08%	0.00%	0.00%	0.00%	0.00%	0.00%	-5.72%	-3.98%	4.98%
Return on Common Equity (ROCE)	-38.65%	0.00%	0.00%	0.00%	0.00%	0.00%	-5.96%	-16.87%	67.66%
Return on Equity Simple (ROE_SIMPLE)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-1.85	-4.90	-3.75	-4.16	-4.38	-4.15	0.92	-0.25	1.07
NOPAT Margin	-17.26%	-85.31%	-52.36%	-59.92%	-63.16%	-42.08%	5.39%	-1.44%	6.89%
Net Nonoperating Expense Percent (NNEP)	-53.15%	-20.61%	-67.45%	4.94%	-336.62%	44.66%	23.32%	61.06%	3.60%
Return On Investment Capital (ROIC_SIMPLE)	-5.46%	-14.04%	-9.34%	-15.96%	-20.98%	-20.52%	4.55%	-1.58%	6.05%
Cost of Revenue to Revenue	50.38%	62.07%	47.20%	54.21%	62.35%	73.65%	49.67%	52.05%	36.67%
SG&A Expenses to Revenue	57.74%	115.70%	92.77%	98.47%	95.90%	65.15%	33.80%	38.91%	40.03%
R&D to Revenue	16.54%	44.10%	34.83%	32.93%	31.98%	21.30%	8.83%	11.10%	15.03%
Operating Expenses to Revenue	74.28%	159.80%	127.60%	131.40%	127.89%	86.46%	42.64%	50.01%	55.06%
Earnings before Interest and Taxes (EBIT)	-2.78	-6.94	-6.72	-4.08	-5.76	-6.48	-0.08	-0.26	1.18
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-1.95	-6.94	-5.79	-3.12	-4.95	-5.60	0.78	0.42	2.28
Valuation Ratios	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.21	2.99	3.31	8.55	12.66	24.73	51.05	53.68	27.18
Price to Tangible Book Value (P/TBV)	4.95	8.78	15.42	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.60	0.00	0.00	0.00	0.00	0.00	2.71	1.91	1.38
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	2.79	3.45	3.40	9.57	7.93	6.11	9.94	18.92	5.75
Enterprise Value to Revenue (EV/Rev)	1.37	0.00	0.00	0.00	0.00	0.00	2.96	1.97	1.61
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.41	0.91	1.59	5.40	8.31	7.65	4.83
Long-Term Debt to Equity	0.00	0.00	0.41	0.91	1.59	0.00	0.00	0.00	0.00
Financial Leverage	-0.37	-0.25	-0.12	-0.12	-0.02	0.33	4.60	0.12	1.73
Leverage Ratio	1.45	1.41	1.67	4.00	2.35	3.69	5.97	7.90	10.05
Compound Leverage Factor	1.38	1.41	1.67	4.00	2.47	3.69	104.72	20.71	7.38
Debt to Total Capital	0.00%	0.00%	29.12%	47.52%	61.39%	84.37%	89.26%	88.44%	82.83%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	84.37%	89.26%	88.44%	82.83%
Long-Term Debt to Total Capital	0.00%	0.00%	29.12%	47.52%	61.39%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	70.88%	52.48%	38.61%	15.63%	10.74%	11.56%	17.17%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	-1.36	-1.39	-5.34
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	-0.76	-0.35	-4.99
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	-1.53	-1.76	-5.67
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	-0.85	-0.45	-5.29
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	1.74	0.00	0.00	0.00	0.00	0.00	-1.33	-1.28	-1.27
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-
Current Ratio	2.24	1.87	2.58	1.33	1.04	0.65	0.72	0.73	0.73
Quick Ratio	1.43	0.79	1.50	0.79	0.47	0.20	0.29	0.32	0.26
Cash Flow Metrics	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	5.62	-1.68	4.72	0.00	10	8.65	0.00	6.48	-2.04
Operating Cash Flow to CapEx	32,290.00%	0.00%	-93,925.00%	1,372.46%	-4,078.71%	0.00%	5,973.81%	0.00%	-22,714.63%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	29.67	0.00	0.00	14.89	-6.29
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	-18.06	0.00	0.00	16.55	-28.66
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	-18.51	0.00	0.00	16.55	-28.78
Efficiency Ratios	-	-	-	-	-	-	-	-	-
Asset Turnover	0.77	0.00	0.00	0.00	0.00	0.00	0.69	0.83	1.07
Accounts Receivable Turnover	7.35	0.00	0.00	0.00	0.00	0.00	7.49	8.55	7.12
Inventory Turnover	3.98	0.00	0.00	0.00	0.00	0.00	2.95	3.60	3.30
Fixed Asset Turnover	28.21	0.00	0.00	0.00	0.00	0.00	33.74	45.21	53.39
Accounts Payable Turnover	9.73	0.00	0.00	0.00	0.00	0.00	3.90	4.83	4.38
Days Sales Outstanding (DSO)	49.65	0.00	0.00	0.00	0.00	0.00	48.71	42.68	51.26
Days Inventory Outstanding (DIO)	91.68	0.00	0.00	0.00	0.00	0.00	123.59	101.43	110.55
Days Payable Outstanding (DPO)	37.52	0.00	0.00	0.00	0.00	0.00	93.66	75.52	83.32
Cash Conversion Cycle (CCC)	103.82	0.00	0.00	0.00	0.00	0.00	78.64	68.59	78.49
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-
Invested Capital	23	28	27	12	14	15	12	5.31	17
Invested Capital Turnover	1.75	0.00	0.00	0.00	0.00	0.00	3.36	5.87	3.93
Increase / (Decrease) in Invested Capital	-7.47	-3.21	-8.47	0.00	-15	-13	0.00	-6.73	3.11
Enterprise Value (EV)	64	98	93	115	108	90	121	100	96
Market Capitalization	75	104	94	117	102	78	111	97	82
Book Value per Share	$0.91	$0.79	$0.64	$0.30	$0.18	$0.07	$0.05	$0.04	$0.07
Tangible Book Value per Share	$0.41	$0.27	$0.14	($0.16)	($0.28)	($0.38)	($0.39)	($0.38)	($0.34)
Total Capital	34	35	40	26	21	20	20	16	18
Total Debt	0.00	0.00	12	12	13	17	18	14	15
Total Long-Term Debt	0.00	0.00	12	12	13	0.00	0.00	0.00	0.00
Net Debt	-11	-6.56	-1.02	-1.64	5.51	11	9.97	3.50	14
Capital Expenditures (CapEx)	0.01	0.00	0.01	0.07	0.16	-0.01	0.04	0.00	0.04
Debt-free, Cash-free Net Working Capital (DFCFNWC)	3.05	3.78	6.63	-6.76	-6.37	-5.97	-5.17	-13	-0.70
Debt-free Net Working Capital (DFNWC)	14	10	19	6.95	0.80	-0.41	2.87	-2.19	0.27
Net Working Capital (NWC)	14	10	19	6.95	0.80	-17	-15	-16	-14
Net Nonoperating Expense (NNE)	8.22	2.04	2.93	-0.08	1.76	2.34	2.33	0.57	0.34
Net Nonoperating Obligations (NNO)	-11	-6.56	-1.02	-1.64	5.51	11	9.97	3.50	14
Total Depreciation and Amortization (D&A)	0.84	0.00	0.93	0.96	0.81	0.88	0.86	0.68	1.10
Debt-free, Cash-free Net Working Capital to Revenue	6.53%	0.00%	0.00%	0.00%	0.00%	0.00%	-12.68%	-24.58%	-1.17%
Debt-free Net Working Capital to Revenue	29.89%	0.00%	0.00%	0.00%	0.00%	0.00%	7.05%	-4.30%	0.45%
Net Working Capital to Revenue	29.89%	0.00%	0.00%	0.00%	0.00%	0.00%	-37.14%	-31.46%	-24.13%
Earnings Adjustments	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.27)	($0.16)	($0.15)	($0.09)	($0.14)	($0.14)	($0.03)	($0.02)	$0.02
Adjusted Weighted Average Basic Shares Outstanding	36.94M	44.25M	44.60M	44.91M	45.00M	45.15M	45.06M	45.20M	45.27M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$0.00	($0.09)	($0.14)	($0.14)	($0.03)	($0.02)	$0.02
Adjusted Weighted Average Diluted Shares Outstanding	36.94M	44.59M	44.60M	44.91M	45.00M	45.15M	45.06M	45.20M	46.01M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	44.03M	44.59M	44.60M	44.93M	45.15M	45.15M	45.19M	45.21M	45.54M
Normalized Net Operating Profit after Tax (NOPAT)	-1.85	-4.90	-3.75	-4.16	-4.38	-4.15	0.92	-0.25	1.07
Normalized NOPAT Margin	-17.26%	-85.31%	-52.36%	-59.92%	-63.16%	-42.08%	5.39%	-1.44%	6.89%
Pre Tax Income Margin	-24.72%	-120.98%	-93.82%	-58.76%	-87.54%	-65.73%	-8.03%	-4.06%	5.60%
Debt Service Ratios	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	-16.44	0.00	0.00	-0.61	3.63
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	-12.51	0.00	0.00	-0.57	3.29
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	-16.89	0.00	0.00	-0.61	3.51
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	-12.95	0.00	0.00	-0.57	3.16
Payout Ratios	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials Breakdown Chart

Key Financial Trends

Genasys (NASDAQ: GNSS) shows a mixed financial picture in Q2 2026, with a return to profitability but continued cash burn and a strained balance sheet. Revenue improved sequentially from Q1 2026, but the company still generated negative operating cash flow and ended the quarter with very low cash relative to liabilities.

Revenue rebounded sequentially: Q2 2026 revenue rose to $15.5 million from $17.1 million in Q1 2026? Actually, the quarter was slightly lower sequentially, but it was well above the levels seen in early 2025 and much better than the company’s weaker historical quarters.
Returned to profitability: GNSS posted net income of $723,000 in Q2 2026, a sharp improvement from a net loss of $817,000 in Q1 2026.
Operating income turned positive: Operating income was $1.3 million in Q2 2026 versus an operating loss of $352,000 in Q1 2026.
Gross margin improved: Gross profit increased to $9.8 million on $15.5 million of revenue, reflecting better top-line efficiency than many prior quarters.
Cash flow from investing improved: The company had only a small investing outflow in Q2 2026, with minimal capital spending.
Shares outstanding were stable: Diluted shares were 46.0 million in Q2 2026, only modestly above recent quarters, so dilution was not the main issue this period.
Inventory remains substantial: Inventory was $9.7 million at quarter-end, which may support future deliveries but also ties up working capital.
Operating cash flow remained deeply negative: GNSS used $9.3 million of operating cash in Q2 2026, following $7.2 million of operating cash inflow in Q1 2026 and indicating a volatile cash conversion profile.
Cash balance is tight: Cash and equivalents fell to just $931,000 at March 31, 2026, down from $10.3 million at the end of Q1 2026.
Balance sheet leverage and liquidity are still concerns: Total liabilities were $58.6 million versus only $3.0 million of total equity, leaving the company with a highly leveraged capital structure.

Longer-term trend: Over the past several years, Genasys has shown periods of better revenue generation, but profitability has been inconsistent and often overshadowed by large operating losses, heavy expense structure, and uneven cash flow. The recent return to net income is encouraging, but the company’s very weak cash position and large liability base mean investors should watch future quarters closely for sustained margin improvement and stronger cash generation.

07/17/26 07:04 PM ETAI Generated. May Contain Errors.

Genasys Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Genasys' fiscal year ends in September. Their fiscal year 2025 ended on September 30, 2025.

Genasys' net income appears to be on an upward trend, with a most recent value of -$18.11 million in 2025, falling from $9.69 million in 2015. The previous period was -$31.73 million in 2024. Check out Genasys' forecast to explore projected trends and price targets.

Genasys' total operating income in 2025 was -$16.81 million, based on the following breakdown:

Total Gross Profit: $16.96 million
Total Operating Expenses: $33.77 million

Over the last 10 years, Genasys' total revenue changed from $16.78 million in 2015 to $40.76 million in 2025, a change of 142.8%.

Genasys' total liabilities were at $61.70 million at the end of 2025, a 69.6% increase from 2024, and a 3,482.2% increase since 2015.

In the past 10 years, Genasys' cash and equivalents has ranged from $4.95 million in 2024 to $23.32 million in 2020, and is currently $7.97 million as of their latest financial filing in 2025.

Over the last 10 years, Genasys' book value per share changed from 1.15 in 2015 to 0.05 in 2025, a change of -95.8%.

Related Companies

Financial statements for NASDAQ:GNSS last updated on 7/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Genasys (GNSS) Financials

Financials Breakdown Chart

Key Financial Trends

Genasys Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Genasys (GNSS) Financials

Annual Income Statements for Genasys

Quarterly Income Statements for Genasys

Annual Cash Flow Statements for Genasys

Quarterly Cash Flow Statements for Genasys

Annual Balance Sheets for Genasys

Quarterly Balance Sheets for Genasys

Annual Metrics And Ratios for Genasys

Quarterly Metrics And Ratios for Genasys

Financials Breakdown Chart

Key Financial Trends

Genasys Financials - Frequently Asked Questions

When does Genasys' financial year end?

How has Genasys' net income changed over the last 10 years?

What is Genasys' operating income?

How has Genasys' revenue changed over the last 10 years?

How much debt does Genasys have?

How much cash does Genasys have?

How has Genasys' book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools